Latest Stock Split Details
Key information about Medite Cancer Diagnostics, Inc.'s most recent stock split
Split Date: 2015-03-12
Split Ratio: 1:100
Price Before Split: $0.02
Price After Split: $0.00
Developer API
Get MDIT split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/MDIT
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 100.00 times fewer shares (a 1:100 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Medite Cancer Diagnostics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2015-03-12 | 1:100 | Yes | $0.02 | $0.00 |
| 2007-11-28 | 1:10 | Yes | $0.25 | $0.03 |
| 1983-06-06 | 3:2 | No | N/A | N/A |
About Medite Cancer Diagnostics, Inc.
Company overview and industry information
Medite Cancer Diagnostics, Inc. (MDIT) operates in the Medical - Specialties industry. The recent 1-for-100 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Medical - Specialties
Go to Medite Cancer Diagnostics, Inc. Summary